Chemoinformaics analysis of dodeca-2-trans-4-cis-8,10-diynoic acid isobutylamide
| Molecular Weight | 494.764 | nRot | 16 |
| Heavy Atom Molecular Weight | 444.364 | nRig | 5 |
| Exact Molecular Weight | 494.387 | nRing | 0 |
| Solubility: LogS | -3.12 | nHRing | 0 |
| Solubility: LogP | 3.603 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 86 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 36 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 50 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 90.5836 |
| nHD | 2 | BPOL | 53.0364 |
| QED | 0.65 |
| Synth | 3.13 |
| Natural Product Likeliness | 0.894 |
| NR-PPAR-gamma | 0.01 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.18 |
| Pgp-sub | 0.004 |
| HIA | 0.004 |
| CACO-2 | -4.594 |
| MDCK | 0.0000218 |
| BBB | 0.506 |
| PPB | 0.953523 |
| VDSS | 0.88 |
| FU | 0.0358618 |
| CYP1A2-inh | 0.334 |
| CYP1A2-sub | 0.142 |
| CYP2c19-inh | 0.346 |
| CYP2c19-sub | 0.689 |
| CYP2c9-inh | 0.39 |
| CYP2c9-sub | 0.506 |
| CYP2d6-inh | 0.042 |
| CYP2d6-sub | 0.833 |
| CYP3a4-inh | 0.185 |
| CYP3a4-sub | 0.241 |
| CL | 7.261 |
| T12 | 0.785 |
| hERG | 0.274 |
| Ames | 0.348 |
| ROA | 0.817 |
| SkinSen | 0.985 |
| Carcinogencity | 0.42 |
| EI | 0.458 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.134 |
| Antiviral | No |
| Prediction | 0.560647 |